Showing results (131-140 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|September 18, 2017
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialFei-Er Feng, Ru Feng, Min Wang, et al.
The Lancet. Haematology|December 3, 2017
Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trialSim Y Ong, Lyle C Gurrin, Lara Dolling, et al.
The Lancet. Haematology|July 25, 2015
Integration of red cell genotyping into the blood supply chain: a population-based studyWilly A Flegel, Jerome L Gottschall, Gregory A Denomme
The Lancet. Haematology|May 22, 2018
Automated typing of red blood cell and platelet antigens: a whole-genome sequencing studyWilliam J Lane, Connie M Westhoff, Nicholas S Gleadall, et al.
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
The Lancet. Haematology|August 18, 2018
Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trialTapan M Kadia, Jorge Cortes, Farhad Ravandi, et al.
The Lancet. Haematology|May 7, 2017
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trialAndrew Davies, Francesco Merli, Biljana Mihaljević, et al.
The Lancet. Haematology|September 24, 2016
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysisYin Ting Cheung, Noah D Sabin, Wilburn E Reddick, et al.
The Lancet. Haematology|April 10, 2018
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trialMartin Wermke, Julia Eckoldt, Katharina S Götze, et al.
The Lancet. Haematology|July 9, 2017
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE studyHagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, et al.
Pageof 73